July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Diabetic rats with endogenously high levels of retinal dopamine do not display retinal vascular hallmarks of diabetic retinopathy
Author Affiliations & Notes
  • Rachael S Allen
    Center for Visual and Neurocognitive Rehabilitation, Atlanta VA Healthcare System, Decatur, Georgia, United States
    Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States
  • Cara Motz
    Center for Visual and Neurocognitive Rehabilitation, Atlanta VA Healthcare System, Decatur, Georgia, United States
    Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States
  • Andrew Feola
    Center for Visual and Neurocognitive Rehabilitation, Atlanta VA Healthcare System, Decatur, Georgia, United States
    Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States
  • Kyle Chesler
    Center for Visual and Neurocognitive Rehabilitation, Atlanta VA Healthcare System, Decatur, Georgia, United States
    Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States
  • Susov Dhakal
    Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, United States
  • Peter M Thule
    Section Endocrinology & Metabolism, Atlanta VA Healthcare System, Decatur, Georgia, United States
    Section Endocrinology & Metabolism, Emory University School of Medicine, Atlanta, Georgia, United States
  • P. Michael Iuvone
    Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, United States
  • Timothy S Kern
    Pharmacology, Case Western Reserve University, Cleveland, Ohio, United States
  • Machelle T Pardue
    Center for Visual and Neurocognitive Rehabilitation, Atlanta VA Healthcare System, Decatur, Georgia, United States
    Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States
  • Footnotes
    Commercial Relationships   Rachael Allen, None; Cara Motz, None; Andrew Feola, None; Kyle Chesler, None; Susov Dhakal, None; Peter Thule, None; P. Michael Iuvone, None; Timothy Kern, None; Machelle Pardue, None
  • Footnotes
    Support  This material is based upon work supported by the Department of Veterans Affairs (Rehabilitation R&D Service Career Development Award-1 (RX002111) to R.S.A; Rehabilitation R&D Service Merit Award (RX002615 and RX000951) and Research Career Scientist Award (RX003134) to M.T.P.), Research to Prevent Blindness (Emory), NIH NEI P30EY06360 (Emory), and Foundation Fighting Blindness.
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6439. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rachael S Allen, Cara Motz, Andrew Feola, Kyle Chesler, Susov Dhakal, Peter M Thule, P. Michael Iuvone, Timothy S Kern, Machelle T Pardue; Diabetic rats with endogenously high levels of retinal dopamine do not display retinal vascular hallmarks of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6439.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Diabetic retinopathy is characterized by retinal and visual dysfunction in early stages and clinically-recognized retinal vascular pathology in late stages. We previously showed that Goto-Kakizaki (GK) rats, a polygenic, non-obese Type II diabetes model, exhibit hyperglycemia and delays in electroretinogram implicit times that are characteristic of the diabetic phenotype. However, GK rats did not show deficits in vascular structure or function. Here, we investigated retinal dopamine as a potential cause of this lack of vascular pathology in the GK rat.

Methods : In male and female GK rats (n = 17) and non-diabetic Wistar controls (n = 20-23), glucose tolerance tests were used to confirm hyperglycemia. Electroretinograms were performed monthly. Functional hyperemia was performed at 8 months to assess retinal vascular function. Retinas from rats euthanized at 8 and 12 months were assessed for vascular pathology. Dopamine levels were measured via HPLC in retinas from rats euthanized at 1, 2, 8, and 12 months.

Results : GK rats showed significant glucose intolerance beginning at 1 month of age (p < 0.001) and persisting to 8 months (p < 0.001). GK rats showed significant increases in a-wave, b-wave, flicker, and oscillatory potential amplitudes (p < 0.01 to p < 0.001), as well as significant delays in flicker and oscillatory potential implicit times (p < 0.05 to p < 0.001) beginning at 1 month and persisting to 8 months. 8-month-old GK rats showed no deficits in retinal vascular function and no increase in degenerate (acellular) retinal capillaries compared with nondiabetic controls. Dopamine levels were significantly higher in GK retinas vs. Wistar retinas – twice as high, on average – at 1, 2, 8, and 12 months (p < 0.001).

Conclusions : GK rats exhibited retinal function deficits by 1 month of age, but vascular pathology was not observed in the GK rat even by 12 months, a time point much later than the 6-8 month window when vascular pathology is usually observed in diabetic rats. GK rats exhibited higher than normal levels of dopamine. Given dopamine’s use as an anti-angiogenic in other diseases, it is possible that the endogenously high levels of dopamine in the GK rat are conferring protection against diabetic vascular pathology. Additionally, this data suggests that neuronal and vascular changes may not be related.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×